Almirall, S.A. (LBTSF) Financials
LBTSF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 2.7 billion | 973.7 million |
| Sept. 30, 2025 | 2.8 billion | 1.0 billion |
| June 30, 2025 | 2.7 billion | 995.8 million |
| March 31, 2025 | 2.6 billion | 969.1 million |
LBTSF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | 105.1 million | ? |
| Sept. 30, 2025 | 140.4 million | ? |
| June 30, 2025 | -48.4 million | ? |
| March 31, 2025 | 13.2 million | ? |
LBTSF Net Income
| Date | Net Income |
|---|---|
| Dec. 31, 2025 | 23.0 million |
| Sept. 30, 2025 | 24.6 million |
| June 30, 2025 | 9.9 million |
| March 31, 2025 | 38.6 million |
LBTSF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 397.6 million | 397.9 million | 40.5 million |
| Sept. 30, 2025 | 442.0 million | 395.6 million | - |
| June 30, 2025 | 381.0 million | 455.1 million | 53.3 million |
| March 31, 2025 | 405.0 million | 369.4 million | - |
LBTSF Shares Outstanding
LBTSF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 27.4 million | 41.8 million | 271.4 million | - |
| Sept. 30, 2025 | - | 63.1 million | 238.4 million | -59.5 million |
| June 30, 2025 | 85.1 million | 15.5 million | -29.2 million | 59.7 million |
| March 31, 2025 | 15.4 million | 38.4 million | 98.8 million | - |
LBTSF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 336.9 million | 426.6 million |
| Sept. 30, 2025 | 305.4 million | 198.4 million |
| June 30, 2025 | 323.4 million | 28.9 million |
| March 31, 2025 | 309.5 million | 101.9 million |
LBTSF
Price: $15.35
Dividend Yield: 1.34%
Forward Dividend Yield: 1.34%
Dividend Per Share: 0.21 USD
Earnings Per Share: 0.26 USD
P/E Ratio: 59.04
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 3.3 billion
Average Dividend Frequency: 1
Years Paying Dividends: 8
DGR3: 2.16%
DGR5: 11.69%